Biomarker-driven medical research involving adults who have or are at risk of developing cancer

Joined November 2013
4,642 Photos and videos
Do you have #AcuteMyeloidLeukemia (#AML) and are age 60 or older? If so, you may be able to participate in this study of a potential new treatment. Learn more: bit.ly/mm1oa-ea02-study #leukemia #leusm
92
The EAF223/GABLE clinical study is testing different imaging techniques that could help make better predictions about #BrainCancer progression. Learn more here: bit.ly/gable-trial cc: @DukeRadiology, @glioblastf, @gbmfoundation
107
Patients with newly diagnosed #MultipleMyeloma may be eligible to participate in #ClinicalTrial EAA181/EQUATE. Learn more here: bit.ly/eaa181equate cc: @myelomaMD, @mtmdphd
93
.@michael_lidsky of @DukeSurgOnc and @DukeCancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: bit.ly/ea2222-pump cc: @CCAlliance, @FightCRC, @NCCRTnews
1
1
114
.@MonikaJoshimd and @PGrivasMDPhD are leading #ClinicalTrial EA8231, a phase 3 randomized trial comparing the effectiveness of pembrolizumab and sacituzumab govitecan to standard-of-care chemo in patients with advanced #UrothelialCancer. bit.ly/ea8231-study
1
2
597
Help potentially improve the future of #HeadAndNeckCancer treatment. Take part in clinical study EA3191 for patients with squamous cell carcinoma of the head and neck (#HNSCC) that has come back. Learn more: bit.ly/ea3191-study #HNCA
67
This #NationalCancerSurvivorsMonth, we're celebrating survivors like Steven Merlin, who turned a #PancreaticCancer diagnosis into a story of hope. Through self-advocacy & participation in a clinical trial, Steven beat the odds & now helps others. More: bit.ly/beatingtheoddsf25
1
179
In #ClinicalTrial EA7222, investigators are testing doxorubicin plus pembrolizumab vs. doxorubicin alone for patients with dedifferentiated #liposarcoma & undifferentiated pleomorphic #sarcoma. For more information: bit.ly/EA7222 #sarcomaawareness
71
#ClinicalTrial EA6244, led by @YanaNajjarMD of @UPMCHillmanCC, is testing a less invasive treatment approach for older adults with early-stage #melanoma. Learn more: bit.ly/ea6244-study
92
The #ComboMATCH Study, led by researchers from @StanfordCancer, @MDAndersonNews, & @theNCI, is testing new combinations of anti-cancer drugs, based on characteristics found in patients’ tumors or blood. Learn more: bit.ly/ComboMATCH #PrecisionMedicine
49
.@eaonc Image Analytics Working Group Chair Dr. Elizabeth McDonald discusses results from a retrospective study showing that GLP-1 treatment was associated w/ a significantly lower incidence of #BreastCancer. Next step? A clinical trial. Watch the video: bit.ly/4aDDAyD
54
Patients with aggressive B-cell #Lymphoma that has recurred or is resistant to treatment may be eligible to participate in #ClinicalTrial EA4231. Learn more here: bit.ly/EA4231 cc: @MelanicjMD, @theNCI, @UVACancerCenter
1
73
Urothelial cancer is the most common type of #bladdercancer. The EA8192 study is evaluating durvalumab and chemotherapy for patients with high grade upper tract urothelial cancer prior to nephroureterectomy. bit.ly/ea8192-trial cc: @BladderCancerUS @JCensits @PGrivasMDPhD
1
1,135
The #BreastCancer study EA1242/RxFINE-Low is testing whether #HormoneTherapy plus ribociclib, without #Chemotherapy, is as effective as standard treatment that includes chemotherapy. Learn more: bit.ly/ea1242-study #BCSM #BreastCancerAwareness
1
80
#ClinicalTrial EA5221/ACHIEVE, led by Dr. Megan Baumgart of @URMC_DeptMed & @WilmotCancer, aims to help older patients with #LungCancer live longer while also maintaining a good quality of life. Learn more: bit.ly/ea5221-achieve #NSCLC #LCSM
1
1
114
Congratulations to @HwakeleeMD, on being named a 2026 Giant of Cancer Care in Thoracic Malignancies 👏 A well-deserved recognition of her leadership in advancing #LungCancer research and improving patient outcomes. Learn more: bit.ly/43VW0XG
1
141
ECOG-ACRIN Cancer Research Group retweeted
Chairs @ALLIANCE_org @SWOG @EAONC myeloma committees. IMWG meeting. @szusmani @DoctorAKrishnan @VincentRK
4
16
80
5,883
Can patients with high-risk retroperitoneal #sarcoma benefit from neoadjuvant chemotherapy? The international EA7211/STRASS 2 #ClinicalTrial, led in the US by @kencardonaMD, aims to find out. Learn more: bit.ly/EA7211 #leiomyosarcoma #liposarcoma cc: @EORTC
1
454